Study on the manifestation and discriminant validity of some clinical and sub-clinical features between surviving and death groups in patients with severe dengue fever

  • Nguyễn Minh Nam Viện Nghiên cứu Y Dược học Quân sự
  • Đỗ Tuấn Anh Bệnh viện Quân y 103
  • Lê Văn Nam Bệnh viện Quân y 103
  • Hoàng Văn Tổng Viện Nghiên cứu Y Dược học Quân sự

Main Article Content

Keywords

Severe dengue fever, clinical features, laboratory features

Abstract

Objective: To determine the manifestations and discriminant validity of some clinical and laboratory test features between survival and death groups in patients with severe dengue hemorrhagic fever. Subject and method: Using comparative description and ROC curve to determine discriminant validity of some clinical and laboratory test features in 68 patients with severe dengue fever at Military Hospital 103. Result: The proportion of patients with underlying diseases, symptoms of consciousness disorder, and shock in the survival group were 34%, 4%, 16%, and that in the death group were 77.8%, 33.3%, 61.1% respectively. The number of white blood cells, neutrophils, creatinine, APTT time, CRP in the death group were higher than that in the survival group. Red blood cell counts, hemoglobin, hematocrit and prothrombin ratio in the death group were lower than that in the survival group. The AUC values of age, white blood cell count, neutrophil count, creatinine, APTT, red blood cell count, hemoglobin, hematocrit and prothrombin ratio to distinguish between the survival and death groups range from 0.7 to 0.8 with p<0.05; Conclusion: The death group had a higher rate of underlying disease, shock, consciousness disorder than that in the survival group. Age, white blood cell count, neutrophil count, creatinine, APTT, red blood cell count, hemoglobin, hematocrit can be used to distinguish between survival and death groups in patients with severe dengue fever (p<0,05).

Article Details

References

1. WHO (2023) Update on the Dengue situation in the Western Pacific Region. Dengue Situation Update 683.
2. Tejo AM, Hamasaki DT, Menezes LM et al (2024) Severe dengue in the intensive care unit. Journal of Intensive Medicine 4(01): 16-33.
3. Bộ Y tế (2023) Quyết định về việc ban hành hướng dẫn chẩn đoán, điều trị sốt xuất huyết Dengue, Số 2760/QĐ-BYT.
4. Yang S, Berdine G (2017) The receiver operating characteristic (ROC) curve. The Southwest Respiratory Critical Care Chronicles 5(19): 34-36.
5. Md-Sani SS, Md-Noor J, Han WH et al (2018) Prediction of mortality in severe dengue cases. BMC infectious diseases 18: 1-9.
6. Pinto RC, Castro DB, Albuquerque BC et al (2016) Mortality predictors in patients with severe dengue in the State of Amazonas, Brazil. PloS one 11(8): 0161884.
7. Tantawichien T (2015) Dengue fever and dengue hemorrhagic fever in adults. Southeast Asian J Trop Med Public Health 46 (Suppl 1): 79-98.
8. Almas A, Parkash O, Akhter J (2010) Clinical factors associated with mortality in dengue infection at a tertiary care center. Southeast Asian J Trop Med Public Health 41(2): 333-340.
9. Vogt MB, Lahon A, Arya RP et al (2019) Dengue viruses infect human megakaryocytes, with probable clinical consequences. PLoS neglected tropical diseases 13(11): 0007837.
10. Leowattana W, Leowattana T (2021) Dengue hemorrhagic fever and the liver. World journal of hepatology 13(12): 1968.
11. Mahmood A, Haq A, Amin S et al (2023) Predictors of mortality in patients with dengue fever: Insights from a comparative analysis. Cureus 15(3).